logo image
search icon
Global Direct-to-Consumer Genetic Testing Market

Direct-to-Consumer Genetic Testing Market, Share & Trends Analysis Report, By Type (Nutrigenomics Testing, Predictive testing, Carrier Testing, Others), Type of Technology (Whole Genome Sequencing, Single Nucleotide, Polymorphism Chips, Targeted Analysis, Others), By Distribution Channel, By Region, and Segment Forecasts, 2025-2034

Report ID : 1376 | Published : 2025-05-15 | Pages: 180 | Format: PDF/EXCEL/Power BI Dashbord

Global Direct-to-Consumer Genetic Testing Market Size is valued at USD 2.4 Billion in 2024 and is predicted to reach USD 16.2 Billion by the year 2034 at a 21.2% CAGR during the forecast period for 2025-2034.

 direct to customer

Direct access testing, also known as direct-to-consumer (DTC) testing, enables clients to order laboratory tests directly from a laboratory without necessarily involving their healthcare provider. Direct-to-consumer genetic testing provides a person's genetic information without needing a doctor or health insurance company. Customers can send the business a DNA sample and get immediate results. Direct-to-consumer genetic testing, among other things, raises awareness of numerous genetic illnesses that aid in predicting one's health and offer information on standard features and ancestry. DTC genetic testing is quick to deliver findings confidently, inexpensively, and easy to use. Such scenarios will help the market expand beneficially. 

One of the main factors projected to fuel the growth of the direct-to-consumer (DTC) genetic testing market over the anticipated period is the rise in public awareness. The direct-to-consumer (DTC) genetic testing industry is also expected to grow due to the increase in income levels in developing nations. Additionally, the growing need for service personalization will likely create additional chances for the direct-to-consumer (DTC) genetic testing industry to expand over the next few years.

However, direct-to-consumer (DTC) genetic testing market expansion may be hindered in the near future by flaws in the DTC testing kits. Direct-to-consumer (DTC) genetic testing market expansion is anticipated to be hampered over the timeframe due to the rising cost of DTC genetic testing. Furthermore, insufficient data links a particular genetic mutation to a given illness or functionality. Genetic privacy may also be jeopardized if testing businesses utilize their clients' genetic data improperly or if the information is stolen.

Market Segmentation:

The Direct-to-Consumer Genetic Testing Market is segmented based on type, type of technology, and distribution channel. Based on type, the market is segmented into nutrigenomics testing, predictive testing, carrier testing, and others. Based on the type of technology, the market is divided into whole genome sequencing, single-nucleotide polymorphism chips, targeted analysis, and others. Based on the distribution channel, the market is divided into online platforms, OTC.

The Predictive Testing Segment is Expected to Have the Highest Growth Rate During the Forecast Period

Based on type, the market is segmented into nutrigenomics testing, predictive testing, carrier testing, and others Among these, the predictive testing segment is expected to have the highest growth rate during the forecast period. his segment is also expected to experience the fastest growth over the forecast period. The popularity of predictive testing is driven by consumers' increasing interest in understanding their genetic predispositions to various health conditions, enabling proactive health management. Predictive genetic tests offer valuable information on potential health risks, giving consumers a sense of control over their health and the ability to make informed decisions. Tests that assess genetic risks for common diseases like breast cancer (or cardiovascular disease are particularly popular.

The Whole Genome Sequencing (WGS) Segment Dominates the Market

Based on the type of technology, the market is divided into whole genome sequencing, single-nucleotide polymorphism chips, targeted analysis, and others.  The whole genome sequencing (WGS) segment dominates the market. Advancements in sequencing technologies and a reduction in the cost of genome sequencing have made WGS more affordable and accessible to consumers. The initial high cost of whole genome sequencing has decreased significantly, making it a viable option for direct-to-consumer testing. WGS offers high accuracy and reliability in identifying genetic variations across the entire genome. This comprehensive data allows for a more precise understanding of an individual's genetic predispositions and potential health risks.

The North American Direct-To-Consumer Genetic Testing Market Holds A Significant Revenue Share In The Region.

In the forecast period, North America to hold a major global market share. The high prevalence of rare illnesses, the presence of numerous disease registries, a sizable number of R&D centres for ultra-rare diseases, and significant investments in disease detection are all factors that contribute to the region's considerable market share. Customers with a lot of disposable money can spend more on direct-to-consumer genetic testing, like genetic and nutrigenomics testing, which encourages regional growth. In addition, the arrival of significant industry players in the area and accelerated technology advancements will foster market expansion locally.

During the forecasted years, Asia Pacific is anticipated to experience significant growth. This is primarily due to improvements in awareness and diagnostic skills. Furthermore, this region will benefit financially from implementing frameworks and policies that support illness management. In China, only a relatively smaller percentage of the population uses genetic screening services, although demand is augmenting. With this, many foreign businesses are anticipated to enter the China direct-to-consumer genetic testing industry to offer affordable services.

Recent Developments:

  • In Feb 2025, Myriad Genetics, Inc, announced that the United States Patent and Trademark Office has issued two new patents that further advance Myriad’s ability to bring its tumor-informed, high-definition, molecular residual disease (MRD) assay to market.Myriad’s Precise MRD test is a whole-genome sequencing (WGS)-based assay, enabling the custom selection of hundreds to thousands of targeted variants for deep analysis. Myriad’s MRD assay targets 1,000 sites specific to the tumor genome, enabling sensitive detection of very low tumor levels.
  • In Jan 2022, 23andMe Holding Co obtained FDA approval for a genetic health risk assessment of a marker for hereditary prostate cancer. After the FDA previously authorized 23andMe's BRCA1/BRCA2 (Selected Variants) Genetic Health Risk report and cleared it for MUTYH-Associated Polyposis (MAP), a hereditary colorectal cancer syndrome, this is the company's third cancer risk report clearance.

Competitive Landscape

Some Major Key Players In The Direct-To-Consumer Genetic Testing Market:

  • 23andme Inc.,
  • 24Genetics,
  • Atlas Biomed,
  • Color Genomics,
  • DNAfit,
  • Gene by Gene,
  • Chengdu Twenty-Three Rubik’s Cube Biotechnology Co., Ltd.,
  • EasyDNA,
  • Mapmygenome,
  • MyHeritage Ltd.,
  • Laboratory Corporation of America Holdings,
  • Myriad Genetics, Inc.,
  • Konica Minolta, Inc.,
  • XCODE Life.

Direct-to-Consumer Genetic Testing Market Report Scope : 

Report Attribute

Specifications

Market Size Value In 2024

USD 2.4 Billion

Revenue Forecast In 2034

USD 16.2 Billion

Growth Rate CAGR

CAGR of 21.2% from 2025 to 2034

Quantitative Units

Representation of revenue in US$ Bn,and CAGR from 2025 to 2034

Historic Year

2021 to 2024

Forecast Year

2025-2034

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Type, Type of Technology, Distribution Channel

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; South Korea; South East Asia;

Competitive Landscape

23andme Inc., 24Genetics, Ancestry.com LLC, Atlas Biomed, Color Genomics, DNAfit, Gene by Gene, Chengdu Twenty-Three Rubik’s Cube Biotechnology Co., Ltd., EasyDNA, Mapmygenome, MyHeritage Ltd., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Konica Minolta, Inc., XCODE Life.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Direct-to-Consumer Genetic Testing Market Snapshot

Chapter 4. Global Direct-to-Consumer Genetic Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Direct-to-Consumer Genetic Testing Market Industry Trends
4.10. Global Direct-to-Consumer Genetic Testing Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034

Chapter 5. Direct-to-Consumer Genetic Testing Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
5.2.1. Nutrigenomics Testing
5.2.2. Predictive testing
5.2.3. Carrier Testing
5.2.4. Others

Chapter 6. Direct-to-Consumer Genetic Testing Market Segmentation 2: By Type of Technology, Estimates & Trend Analysis
6.1. Market Share by Type of Technology, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Technology:
6.2.1. Whole Genome Sequencing
6.2.2. Single Nucleotide Polymorphism Chips
6.2.3. Targeted Analysis
6.2.4. Others

Chapter 7. Direct-to-Consumer Genetic Testing Market Segmentation 3: By Distribution Channel, Estimates & Trend Analysis
7.1. Market Share by Distribution Channel, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
7.2.1. Online Platform
7.2.2. OTC

Chapter 8. Direct-to-Consumer Genetic Testing Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Direct-to-Consumer Genetic Testing Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.2.3. North America Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type of Technology, 2021-2034
8.2.4. North America Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034

8.3. Europe
8.3.1. Europe Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.3.3. Europe Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type of Technology, 2021-2034
8.3.4. Europe Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034

8.4. Asia Pacific
8.4.1. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.4.3. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type of Technology, 2021-2034
8.4.4. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034

8.5. Latin America
8.5.1. Latin America Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.5.3. Latin America Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type of Technology, 2021-2034
8.5.4. Latin America Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034

8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.6.3. Middle East & Africa Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Type of Technology, 2021-2034
8.6.4. Middle East & Africa Direct-to-Consumer Genetic Testing Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034

Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles

9.2.1. 23andMe

9.2.1.1. Business Overview
9.2.1.2. Key Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy

9.2.2. Illumina, Inc.
9.2.3. Family Tree DNA
9.2.4. Ancestry
9.2.5. Myriad Genetics, Inc.
9.2.6. Genesis HealthCare
9.2.7. EasyDNA
9.2.8. Veritas
9.2.9. Full Genomes Corporation, Inc
9.2.10. Living DNA Ltd.
9.2.11. Color Health, Inc.

Segmentation Of Direct-To-Consumer Genetic Testing Market

Direct-to-Consumer Genetic Testing Market - By Type

  • Nutrigenomics Testing
  • Predictive testing
  • Carrier Testing
  • Others

 direct to cusomer

Direct-to-Consumer Genetic Testing Market By Technology

  • Targeted Analysis
  • Single Nucleotide Polymorphisms (SNPs)
  • Whole Genome Sequencing (WGS)
  • Others

Direct-to-Consumer Genetic Testing Market By Distribution Channel-

  • Online Platform
  • Over-the-Counter Channel (OTC)

By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How Big is the Direct-To-Consumer Genetic Testing Market Size?

Direct-to-Consumer Genetic Testing Market is expected to grow at a 21.2% CAGR during the forecast period for 2025-2034.

23andme Inc., 24Genetics, Ancestry.com LLC, Atlas Biomed, Color Genomics, DNAfit, Gene by Gene, Chengdu Twenty-Three Rubik’s Cube Biotechnology Co., L

Type, Type of Technology and Distribution Channel are the key segments of the Direct-to-Consumer Genetic Testing Market.

North America region is leading the Direct-to-Consumer Genetic Testing Market.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Report License Selection

Determine the appropriate license for your report

Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach